Is there an urban-rural-gradient in patients with urinary incontinence?

Por Wille, Sebastian, Katarzyna, Kawa, Ahrens, Ulrike, Eminaga, Okyaz, Engelmann, Udo, Jenny, Paas
Publicado em 2014

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer

Por Eminaga, Okyaz, Abbas, Mahmoud, Hinkelammert, Reemt, Titze, Ulf, Bettendorf, Olaf, Eltze, Elke, Özgür, Enver, Semjonow, Axel
Publicado em 2012

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens

Por Bettendorf Olaf, Koepke Thomas, Abbas Mahmoud, Neumann Joerg, Semjonow Axel, Hinkelammert Reemt, Eminaga Okyaz, Eltze Elke, Dugas Martin
Publicado em 2010-11-01

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens

Por Eminaga, Okyaz, Hinkelammert, Reemt, Semjonow, Axel, Neumann, Joerg, Abbas, Mahmoud, Koepke, Thomas, Bettendorf, Olaf, Eltze, Elke, Dugas, Martin
Publicado em 2010

Catheterless Long-Term Ambulatory Urodynamic Measurement Using a Novel Three-Device System

Por Wille, Sebastian, Schumacher, Pauline, Paas, Jenny, Tenholte, Dirk, Eminaga, Okyaz, Müller, Ute, Muthen, Noemi, Mehner, Jan, Cornely, Oliver, Engelmann, Udo
Publicado em 2014

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate i...

Por Mikah, Phillip, Krabbe, Laura-Maria, Eminaga, Okyaz, Herrmann, Edwin, Papavassilis, Philipp, Hinkelammert, Reemt, Semjonow, Axel, Schrader, Andres-Jan, Boegemann, Martin
Publicado no BMC Cancer (2016)

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer

Por Gong, Xue, Siprashvili, Zurab, Eminaga, Okyaz, Shen, Zhewei, Sato, Yusuke, Kume, Haruki, Homma, Yukio, Ogawa, Seishi, Khavari, Paul A., Pollack, Jonathan R., Brooks, James D.
Publicado no Oncotarget (2017)

MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study

Por Eminaga, Okyaz, Wei, Wei, Hawley, Sarah J., Auman, Heidi, Newcomb, Lisa F., Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A., Carroll, Peter R., Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Thompson, Ian M., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Fazli, Ladan, Brooks, James D.
Publicado no PLoS One (2016)